Your browser doesn't support javascript.
loading
Prostate cancer tends to metastasize in the bone-mimicking microenvironment via activating NF-κB signaling.
Tong, Hai-Bo; Zou, Chun-Lin; Qin, Si-Yuan; Meng, Jie; Keller, Evan T; Zhang, Jian; Lu, Yi.
Afiliação
  • Tong HB; Key Laboratory of Longevity and Aging-related Diseases, Guangxi Medical University, Ministry of Education, Nanning, Guangxi 530021, China.
  • Zou CL; Southern University of Science and Technology School of Medicine, Shenzhen, Guangdong 518055, China.
  • Qin SY; Key Laboratory of Longevity and Aging-related Diseases, Guangxi Medical University, Ministry of Education, Nanning, Guangxi 530021, China.
  • Meng J; Key Laboratory of Longevity and Aging-related Diseases, Guangxi Medical University, Ministry of Education, Nanning, Guangxi 530021, China.
  • Keller ET; Southern University of Science and Technology School of Medicine, Shenzhen, Guangdong 518055, China.
  • Zhang J; Key Laboratory of Longevity and Aging-related Diseases, Guangxi Medical University, Ministry of Education, Nanning, Guangxi 530021, China.
  • Lu Y; Southern University of Science and Technology School of Medicine, Shenzhen, Guangdong 518055, China.
J Biomed Res ; 32(5): 343-353, 2018 Sep 29.
Article em En | MEDLINE | ID: mdl-30190448
Prostate cancer preferentially metastasizes to the bone. However, the underlying molecular mechanisms are still unclear. To explore the effects of a bone-mimicking microenvironment on PC3 prostate cancer cell growth and metastasis, we used osteoblast differentiation medium (ODM; minimal essential medium alpha supplemented with L-ascorbic acid) to mimic the bone microenvironment. PC3 cells grown in ODM underwent epithelial-mesenchymal transition and showed enhanced colony formation, migration, and invasion abilities compared to the cells grown in normal medium. PC3 cells grown in ODM showed enhanced metastasis when injected in mice. A screening of signaling pathways related to invasion and metastasis revealed that the NF-κB pathway was activated, which could be reversed by Bay 11-7082, a NF-κB pathway inhibitor. These results indicate that the cells in different culture conditions manifested significantly different biological behaviors and the NF-κB pathway is a potential therapeutic target for prostate cancer bone metastasis.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article